NXTC NEXTCURE INC revenue, earnings and financials
For the quarter ended June 30, 2026, NEXTCURE INC reported revenue of n/a, net income of −$14.9M and diluted EPS of −$2.80; for the fiscal year ended December 2025 revenue was n/a.
NXTC annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$57.6M, net income −$55.8M (margin n/a), EPS −$19.65
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$59.7M, net income −$55.7M (margin n/a), EPS −$23.88
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$67.6M, net income −$62.7M (margin n/a), EPS −$2.25
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$75.9M, net income −$74.7M (margin n/a), EPS −$2.69
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$70.8M, net income −$69.4M (margin n/a), EPS −$2.51
NXTC quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$14.9M, EPS −$2.80
- Quarter ended Mar 31, 2026: revenue n/a, net income −$9.80M, EPS −$1.87
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$9.44M, EPS −$0.44
- Quarter ended Sep 30, 2025: revenue n/a, net income −$8.62M, EPS −$3.22
- Quarter ended Jun 30, 2025: revenue n/a, net income −$26.8M, EPS −$11.29
- Quarter ended Mar 31, 2025: revenue n/a, net income −$11.0M, EPS −$4.70
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$11.6M, EPS −$11.71
- Quarter ended Sep 30, 2024: revenue n/a, net income −$11.5M, EPS −$4.95
- Quarter ended Jun 30, 2024: revenue n/a, net income −$15.4M, EPS −$6.61
- Quarter ended Mar 31, 2024: revenue n/a, net income −$17.1M, EPS −$0.61
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$14.5M, EPS −$0.52
- Quarter ended Sep 30, 2023: revenue n/a, net income −$14.3M, EPS −$0.51
- Quarter ended Jun 30, 2023: revenue n/a, net income −$17.9M, EPS −$0.64
- Quarter ended Mar 31, 2023: revenue n/a, net income −$16.1M, EPS −$0.58
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$17.3M, EPS −$0.62
- Quarter ended Sep 30, 2022: revenue n/a, net income −$18.9M, EPS −$0.68
- Quarter ended Jun 30, 2022: revenue n/a, net income −$17.9M, EPS −$0.65
- Quarter ended Mar 31, 2022: revenue n/a, net income −$20.6M, EPS −$0.74
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$16.9M, EPS −$0.61
- Quarter ended Sep 30, 2021: revenue n/a, net income −$17.9M, EPS −$0.65
NXTC cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$49.6M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Dec 2024: operating cash flow −$40.8M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Dec 2023: operating cash flow −$53.0M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Dec 2022: operating cash flow −$53.9M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Dec 2021: operating cash flow −$57.3M, share buybacks n/a, dividends $0.00 per share
NXTC balance sheet
- Jun 30, 2026: cash $15.3M, total assets $22.6M, total liabilities $10.5M, shareholders' equity $12.1M
- Mar 31, 2026: cash $15.2M, total assets $38.0M, total liabilities $11.3M, shareholders' equity $26.7M
- Dec 31, 2025: cash $26.0M, total assets $50.2M, total liabilities $15.2M, shareholders' equity $34.9M
- Sep 30, 2025: cash $7.32M, total assets $39.6M, total liabilities $16.0M, shareholders' equity $23.6M
- Jun 30, 2025: cash $4.89M, total assets $47.7M, total liabilities $16.0M, shareholders' equity $29.6M
- Mar 31, 2025: cash $21.8M, total assets $67.1M, total liabilities $11.3M, shareholders' equity $55.9M
- Dec 31, 2024: cash $27.7M, total assets $80.9M, total liabilities $15.4M, shareholders' equity $65.5M
- Sep 30, 2024: cash $27.7M, total assets $90.3M, total liabilities $14.8M, shareholders' equity $75.6M
Is NXTC profitable?
No. NEXTCURE INC lost $42.7M over the last four quarters.
What is NXTC's EPS?
Diluted earnings per share over the last four quarters were −$8.33; −$2.80 in the latest quarter.